Shenzhen Edge Medical Co (HKSE:02675) Notes Receivable: HK$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02675 Shenzhen Edge Medical Co Ltd HKSE:02675
11 GF Score
Price HK$38.38
! 3 Warning Signs
View Full Analysis

What is Shenzhen Edge Medical Co Notes Receivable?

Shenzhen Edge Medical Co HKSE:02675 -2.93% 11 Notes Receivable is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02675 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Shenzhen Edge Medical Co's Notes Receivable for the quarter that ended in Dec. 2025 was HK$0.0 Mil.

Shenzhen Edge Medical Co Notes Receivable Related Terms

Shenzhen Edge Medical Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Shenzhen Edge Medical Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Edge Medical Co Notes Receivable Chart

Shenzhen Edge Medical Co Annual Data
Trend Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00

Shenzhen Edge Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable 0.00 0.00 0.00 0.00 0.00
HKSE:02675
11GF Score
Shenzhen Edge Medical Co Ltd HKSE:02675
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen Edge Medical Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of HK$0.0 Mil mean?
Shenzhen Edge Medical Co (HKSE:02675) has a Notes Receivable of HK$0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Shenzhen Edge Medical Co and its competitors.
Is Shenzhen Edge Medical Co's Notes Receivable too high?
Shenzhen Edge Medical Co's current Notes Receivable is HK$0.0 Mil. Overall, Shenzhen Edge Medical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's Notes Receivable compare to ABT and SYK?
Shenzhen Edge Medical Co's Notes Receivable of HK$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Shenzhen Edge Medical Co and its competitors. Shenzhen Edge Medical Co's current Notes Receivable is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (HKSE:02675) has a current Notes Receivable of HK$0.0 Mil. The current Notes Receivable is HK$0.0 Mil. Shenzhen Edge Medical Co's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Shenzhen Edge Medical Co (HKSE:02675), the current Notes Receivable is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenzhen Edge Medical Co Business Description

Other Exchanges R5Z:Germany
Address Baolong Street, Room 1901, Building 2B, Smart Park Phase II, Longgang District, Shenzhen, CHN
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
11GF Score

Get the complete analysis for HKSE:02675

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$38.38
Price